Uptake and continuous use of copper intrauterine device in a cohort of HIV-positive women

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 25, Issue 6, 2013, Pages 710-714

  Landolt, Nadia Kancheva ^a   Phanuphak, Nittaya ^b,c   Teeratakulpisarn, Nipat ^b   Kriengsinyot, Rosalin ^b   Ahluwalia, Jennisa ^a   Pinyakorn, Suteeraporn ^a   Chaithongwongwatthana, Surasith ^d   Ananworanich, Jintanat ^a,b,c,d  

^a THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^b THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^c South East Asia Research Collaboration with Hawaii ^*  (Thailand)

^d CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Continuous contraceptive use; Family planning; HIV positive women; Uptake of intrauterine device

Indexed keywords

COPPER INTRAUTERINE DEVICE;

ADULT; ARTICLE; COHORT ANALYSIS; CONTRACEPTION; DYSMENORRHEA; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; PRIORITY JOURNAL; SPOTTING; THAILAND; ADVERSE EFFECTS; CONDOM; CONTRACEPTIVE BEHAVIOR; COPPER INTRAUTERINE DEVICE; DEVELOPING COUNTRY; FAMILY PLANNING; PREGNANCY; PROCEDURES; PSYCHOLOGY; RISK ASSESSMENT; SEXUAL BEHAVIOR; STATISTICS AND NUMERICAL DATA; TRANSMISSION; UTILIZATION;

ADULT; CONDOMS; CONTRACEPTION; CONTRACEPTION BEHAVIOR; DEVELOPING COUNTRIES; FAMILY PLANNING SERVICES; FEMALE; HIV INFECTIONS; HUMANS; INTRAUTERINE DEVICES, COPPER; PREGNANCY; RISK ASSESSMENT; SEXUAL BEHAVIOR; THAILAND;

EID: 84879209983     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540121.2012.752786     Document Type: Article

References (20)

1. Arrowsmith, M. E., Aicken, C. R., Saxena, S., & Majeed, A. (2012). Strategies for improving the acceptability and acceptance of the copper intrauterine device. Cochrane Database of Systematic Reviews, 14(3), D008896.
2. Cleland, J., Bernstein, S., Ezeh, A., Faundes, A., Glasier, A., & Innis, J. (2006). Family planning: The unfinished agenda. Lancet, 368(9549), 1810-1827.
3. Cohen, C. R., Lingappa, J. R., Baeten, J. M., Ngayo, M. O., Spiegel, C. A., Hong, T., ⋯ Bukusi, E. A. (2012). Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: A prospective cohort analysis among African couples. PLoS Medicine, 9(6), e1001251.
4. Crede', S., Hoke, T., Constant, D., Green, M. S., Moodley, J., & Harries, J. (2012). Factors impacting knowledge and use of long acting and permanent contraceptive methods by postpartum HIV positive and negative women in Cape Town, South Africa: A cross-sectional study. BMC Public Health, 16(12), 197.
5. Demographic and Health Surveys (DHS) Thailand, 1987, 1997. (2003). Thailand reproductive health profile (unpublished). Retrieved from http://www.searo.who. int/LinkFiles/Family-Planning-Fact-Sheets-thailand.pdf
6. Dhont, N., Ndayisaba, G. F., Peltier, C. A., Nzabonimpa, A., Temmerman, M., & van de Wijgert, J. (2009). Improved access increases postpartum uptake of contraceptive implants among HIV-positive women inRwanda. European Journal of Contraception and Reproductive Health Care, 14(6), 420-425.
7. Grimes, D. A., & Mishell, D. R., Jr (2008). Intrauterinecontraception as an alternative to intervaltubal sterilization. Contraception, 77(1), 6-9.
8. Haddad, L., Nyirenda,M., Cwiak, C., Tweya, H., Feldacker, C., Jamieson, D, ⋯ Phiri, S. (2011). Contraceptive eligibility, choice and acceptance of the copper intrauterine device (IUD) among HIV-clients at an ART clinic in Lilongwe, Malawi. 6th IASCon ference, 2011, International AIDS Society,WEAX0205-oral abstract, Rome, Italy.
9. Hubacher, D., Chen, P. L., & Park, S. (2009). Side effects from the copper IUD: Do they decrease over time? Contraception, 79(5), 356-362.
10. Kancheva Landolt, N., Phanuphak, N., Pinyakorn, S., Lakhonphon, S., Khongpetch, C., Chaithongwongwatthana, S., & Ananworanich, J. (2012). Sexual life, options for contraception and intention for conception in HIV-positive people on successful antiretroviral therapy in Thailand. AIDSCare, 24(7), 897-904.
11. Kikuchi, K., Wakasugi, N., Poudel, K. C., Sakisaka, K., & Jimba, M. (2011). High rate of unintended pregnancies after knowing of HIV infection among HIV positive women under antiretroviral treatment in Kigali, Rwanda. Bioscience Trends, 5(6), 255-263.
12. Mugo, N. R., Heffron, R., Donnell, D., Wald, A., Were, E. O., Rees, H., ⋯ Baeten, J. M. (2011). Increased risk of HIV-1 transmission in pregnancy: A prospective study among African HIV-1-serodiscordant couples. AIDS, 25(15), 1887-1895.
13. Ngubane, N., Patel, D., Newell, M. L., C oovadia, H. M., Rollins,N.,&Coutsoudis,A. (2008).Messages aboutdual contraception in areas of high HIV prevalence are not heeded. South AfricanMedical Journal, 98(3), 209-212.
14. Richardson, B. A., Morrison, C. S., Sekadde-Kigondu, C., Sinei, S. K., Overbaugh, J., Panteleeff, D. D., ⋯ Kreiss, J. K. (1999). Effect of intrauterine device use on cervical shedding of HIV-1 DNA. AIDS, 13(15), 2091-2097.
15. Stephenson, R., Vwalika, B., Greenberg, L., Ahmed, Y., Vwalika, C., Chomba, E., ⋯ Allen, S. (2011). A randomized controlled trial to promote long-term contraceptive use among HIV-serodiscordant and concordant positive couples in Zambia. Journal of Women's Health, 20(4), 567-574.
16. Stringer, E. M., Levy, J., Sinkala, M., Chi, B. H., Matongo, I., Chintu, N., & Stringer, J. S. (2009). HIV disease progression by hormonal contraceptive method: Secondary analysis of a randomized trial. AIDS, 23(11), 1377-1382.
17. Stubbs, E., & Schamp, A. (2008). The evidence is in. Why are IUDs still out?: Family physicians' perceptions of risk and indications. Canadian Family Physician, 54(4), 560-566.
18. Trussell, J., Lalla, A. M., Doan, Q. V., Reyes, E., Pinto, L., & Gricar, J. (2009). Cost effectiveness of contraceptives in the United States. Contraception, 79(1), 5-14.
19. Wilson, T. E., Koenig, L. J., Walter, E., Fernandez, I., & Ethier, K. (2003). Perinatal guidelines evaluation project. Dual contraceptive method use for pregnancy and disease prevention among HIV-infected and HIVuninfected women: The importance of an event-level focus for promoting safer sexual behaviors. Sexually Transmitted Diseases, 30(11), 809-812.
20. World Health Organization (WHO). 2009. Medical eligibility criteria for contraceptive use (4th ed.). Geneva: WHO.